Advertisement
Screener

Allurion Technologies, Inc. (ALUR) Foreign Currency Transaction Gain (Loss), before Tax

1.0 / 5 stars · 8/39 Roast Me

Allurion Technologies, Inc. Foreign Currency Transaction Gain (Loss), before Tax

Allurion Technologies, Inc. (ALUR) reported Foreign Currency Transaction Gain (Loss), before Tax of -$90.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.

Financial Statements › Income Statement › Other Income

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-05-15

  • Allurion Technologies, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$90.00K, a 126.87% decline year-over-year.
  • Allurion Technologies, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-03-31 was $335.00K.
  • Allurion Technologies, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2024-12-31 was -$623.00K, a 243.88% decline year-over-year.
  • Allurion Technologies, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2024-09-30 was $402.00K.
  • Allurion Technologies, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$594.00K, a 430.00% decline from fiscal 2023.
  • Allurion Technologies, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was $180.00K.
Period endForeign Currency Transaction Gain (Loss), before Tax 3 monthForeign Currency Transaction Gain (Loss), before Tax 6 monthForeign Currency Transaction Gain (Loss), before Tax 9 monthForeign Currency Transaction Gain (Loss), before Tax 12 month
2026-03-31-$90.00K
10-Q · filed 2026-05-15
2025-03-31$335.00K
10-Q · filed 2026-05-15
-$288.00K
derived: sum of 2 quarters · filed 2026-05-15
$114.00K
derived: sum of 3 quarters · filed 2026-05-15
$55.00K
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31-$623.00K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-19
-$221.00K
derived: sum of 2 quarters · filed 2025-08-28
-$280.00K
derived: sum of 3 quarters · filed 2025-08-28
-$594.00K
10-K/A · filed 2025-08-19
2024-09-30$402.00K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28
$343.00K
derived: sum of 2 quarters · filed 2025-08-28
$29.00K
10-Q/A · filed 2025-08-28
$462.00K
derived: sum of 4 quarters · filed 2025-08-28
2024-06-30-$59.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28
-$373.00K
10-Q/A · filed 2025-08-28
$60.00K
derived: sum of 3 quarters · filed 2025-08-28
-$144.00K
derived: sum of 4 quarters · filed 2025-08-28
2024-03-31-$314.00K
10-Q/A · filed 2025-08-28
$119.00K
derived: sum of 2 quarters · filed 2025-08-28
-$85.00K
derived: sum of 3 quarters · filed 2025-08-28
-$222.00K
derived: sum of 4 quarters · filed 2025-08-28
2023-12-31$433.00K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28
$229.00K
derived: sum of 2 quarters · filed 2025-08-28
$92.00K
derived: sum of 3 quarters · filed 2025-08-28
$180.00K
10-K/A · filed 2025-08-28
2023-09-30-$204.00K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28
-$341.00K
derived: sum of 2 quarters · filed 2025-08-28
-$253.00K
10-Q/A · filed 2025-08-28
2023-06-30-$137.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28
-$49.00K
10-Q/A · filed 2025-08-28
2023-03-31$88.00K
10-Q/A · filed 2025-08-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Picard Medical, Inc. (PMI)United States$0.011B-0.01
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
CERENOME, INC. (CNSY)United States$0.014B
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
AETHLON MEDICAL INC (AEMD)United States$0.005B